Department of Psychology, University of Houston,Houston, TX 77204–5022, USA.
Behav Ther. 2012 Sep;43(3):506-17. doi: 10.1016/j.beth.2010.08.011. Epub 2011 May 25.
Transdiagnostic cognitive-behavioral treatments (CBT) for anxiety disorders have been gaining increased attention and empirical study in recent years. Despite this, all of the research on transdiagnostic anxiety treatments to date have either not used a control condition, or have relied on no-treatment or delayed-treatment controls, thus limiting inferences about comparative efficacy. The current study was a randomized clinical trial examining the efficacy of a 12-week transdiagnostic cognitive-behavioral group treatment in comparison to a 12-week comprehensive relaxation training program. Results from 87 treatment initiators suggested significant and statistically equivalent/noninferior outcomes across conditions, although relaxation was associated with a greater rate of dropout despite no differences in treatment credibility. No evidence was found for any differential effects of transdiagnostic CBT for any primary or comorbid diagnoses.
近年来,针对焦虑障碍的跨诊断认知行为治疗(CBT)受到了越来越多的关注和实证研究。尽管如此,迄今为止所有关于跨诊断焦虑治疗的研究要么没有使用对照组,要么依赖于无治疗或延迟治疗对照组,因此限制了对比较疗效的推断。本研究是一项随机临床试验,比较了为期 12 周的跨诊断认知行为团体治疗与为期 12 周的综合放松训练计划的疗效。87 名治疗发起者的结果表明,各条件下的结果具有显著且统计学上相等/非劣效性,尽管尽管治疗可信度没有差异,但放松治疗与更高的脱落率相关。没有证据表明跨诊断 CBT 对任何主要或共病诊断有任何差异影响。